Vivos Therapeutics VVOS
NASDAQ VVOS
$0.28 +0.00 (+1.27%)
As of: Aug 20, 2026 · 3:58 PM EDT

Vivos Therapeutics (VVOS) Common Equity (2019 - 2026)

Vivos Therapeutics (VVOS) posted quarterly Common Equity of -$1.1 million for Q1 2026, down 125.82% year-over-year from $4.4 million in Q1 2025, and up 26.58% quarter-over-quarter from -$1.5 million in Q4 2025.

Vivos Therapeutics (VVOS) Common Equity (2019 - 2026) Analysis & Trends

Vivos Therapeutics (VVOS) has reported Common Equity for 8 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Common Equity fell 125.82% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$1.1 million (down 125.82% YoY), while the FY2025 annual figure was -$1.5 million, down 119.49% from the prior year.
  • Common Equity rose to -$1.1 million in Q1 2026 per VVOS's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $21.0 million in Q1 2022 and bottomed at -$1.5 million in Q4 2025.
  • Historically, Common Equity has averaged $5.4 million across 5 years, with a median of $4.6 million in 2025.
  • Annual changes were most pronounced in 2024 — Common Equity soared 16563.04% — and 2026, when it slumped 125.82%.
  • Vivos Therapeutics' Common Equity stood at $4.8 million in 2022, then sank by 91.44% to $411000.0 in 2023, then jumped by 1835.28% to $8.0 million in 2024, then slumped by 119.49% to -$1.5 million in 2025, then climbed by 26.58% to -$1.1 million in 2026.
  • Business Quant data shows VVOS's Common Equity at -$1.1 million in Q1 2026, -$1.5 million in Q4 2025, and $2.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 51.76 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 23.99 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 50.07 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 25.17 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 10.72 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 2.62 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.99 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 13.31 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 7.22 Bn
10 Vivos Therapeutics 4.94 Mn 3.14 Mn 2.95 Mn -3.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.14 Mn
Dec 31, 2025 -1.55 Mn
Sep 30, 2025 2.53 Mn
Jun 30, 2025 4.58 Mn
Mar 31, 2025 4.41 Mn
Dec 31, 2024 7.95 Mn
Sep 30, 2024 7.67 Mn
Jun 30, 2024 6.35 Mn
Mar 31, 2024 582,000.00
Dec 31, 2023 411,000.00
Sep 30, 2023 46,000.00
Jun 30, 2023 2.11 Mn
Mar 31, 2023 6.99 Mn
Dec 31, 2022 4.80 Mn
Sep 30, 2022 9.86 Mn
Jun 30, 2022 14.84 Mn
Mar 31, 2022 21.04 Mn
Dec 31, 2021 25.54 Mn
Sep 30, 2021 32.47 Mn
Jun 30, 2021 36.48 Mn